A common approach is 8 to 12 weeks on protocol followed by 4 weeks off
Its available in a dropper bottle
Phase 2 Clinical Trials Near 1-Month Healing Acceleration (PubMed, 2012) A review of TB4s pre-clinical and clinical dermal healing data confirmed healing acceleration in full-thickness wound models across normal, steroid-treated, diabetic, and aged animal models as well as burn models
Retatrutide Phase 2 data showed insulin resistance reductions of over 50% from baseline at higher doses, with fasting insulin levels dropping by up to 71%
100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes
Moreover, recently it has been reported that the pathway governed by NE2FL2 is not only regulated by the proteasome but also by ATG (Jain et al., 2013)